HOME >> BIOLOGY >> NEWS
Discovery By Fertility Specialist Offers Promise Of Reducing Multiple BirthsTied To Fertility Treatment

ATLANTA -- Preliminary research by a fertility specialist at the University at Buffalo shows for the first time that a hormone whose role in fertility was thought to be limited to triggering ovulation also can support growth of a developing egg follicle during fertility treatment.

Results of the research were presented here today (March 13, 1998) at the annual meeting of the Society for Gynecological Investigation.

The findings suggest that lutenizing hormone (LH), a hormone present in the second half of the menstrual cycle, may perform the critical task of sustaining the growth of egg follicles until ovulation, said Michael W. Sullivan, M.D., UB assistant professor of gynecology and obstetrics and lead researcher on the study.

They have important implications for women undergoing fertility treatments, Sullivan said, because specialists formerly thought the only way to keep a developing egg growing was to administer follicle stimulating hormone, or FSH, which also causes multiple eggs to mature.

By manipulating LH and FSH, Sullivan said it could be possible to sustain the growth and development of one or two follicles in women undergoing fertility treatment while preventing multiple ovulations and thus decreasing the risk of multiple births.

"Nobody has looked at this before, because it wasn't possible until the development of the recombinant form of the two hormones, which happened very recently," Sullivan said. "The finding is very preliminary, but it is promising."

The results are based on a
'"/>

Contact: Lois Baker
baker@newsb.buffalo.edu
716-645-2626
University at Buffalo
13-Mar-1998


Page: 1 2 3 4

Related biology news :

1. Discovery of new shrimp species adds to unique family
2. Discovery of tiny microbes in ancient Greenland glacier may define limits for life on Earth
3. Discovery in parasite movement may offer insights into malaria
4. Scientists find second way to kill cancer cells: Discovery opens possibilities for new therapies
5. GlaxoSmithKline Drug Discovery and Development Research Grant Program 2004
6. Discovery helps explain how cells package DNA
7. Discovery offers clues to origin of life
8. Discovery could improve anemia treatment in patients
9. Discovery could lead to better treatment for cryptosporidum infections
10. Discovery of brain disorder gene paves way for genetic test
11. Discovery may be first plant cell surface molecule that halts cell proliferation

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/14/2017)... IBM ) is introducing several innovative partner startups at VivaTech ... startups and global businesses, taking place in Paris ... will showcase the solutions they have built with IBM Watson ... France is one of the most dynamic ... in the number of startups created between 2012 and 2015*, ...
(Date:4/24/2017)... 2017 Janice Kephart , former ... Strategy Partners, LLP (IdSP) , today issues the ... Trump,s March 6, 2017 Executive Order: Protecting ... can be instilled with greater confidence, enabling the ... refugee applications are suspended by until at least ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by ... Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to ... USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... with the addition of its newest module, US Hemostats & Sealants. , SmartTRAK’s ... hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical ...
(Date:10/12/2017)... , ... October 12, 2017 ... ... has launched Rosalind™, the first-ever genomics analysis platform specifically designed for life ... Named in honor of pioneering researcher Rosalind Franklin, who made a major ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity ... for performing systematic gain-of-function studies. , This complement to loss-of-function studies, such ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ComplianceOnline’s Medical ... place on 7th and 8th June 2018 in San Francisco, CA. The Summit brings ... well as several distinguished CEOs, board directors and government officials from around the world ...
Breaking Biology Technology:
Cached News: